Bacterial membrane activity of -peptide/-peptoid chimeras: Influence of amino acid composition and chain length on the activity against different bacterial strains

BMC Microbiology

Volumn 11, Issue , 2011, Pages

  Hein Kristensen, Line ^a   Knapp, Kolja M ^b   Franzyk, Henrik ^b   Gram, Lone ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA PEPTIDE BETA PEPTOID CHIMERA; CHIMERIC PROTEIN; POLYMYXIN B; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DEPLETION; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MEMBRANE DAMAGE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEIN FUNCTION; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; BACTERIAL INFECTION; CELL MEMBRANE; CHEMISTRY; DRUG EFFECT; FOOD CONTROL; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; STRUCTURE ACTIVITY RELATION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA; POSIBACTERIA; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS;

AMINO ACID SUBSTITUTION; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL INFECTIONS; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; ESCHERICHIA COLI; FOOD MICROBIOLOGY; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79959367332     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-11-144     Document Type: Article

References (62)

1. Antimicrobial peptides of multicellular organisms. M Zasloff, Nature 2002 415 389 395 10.1038/415389a 11807545 (Pubitemid 34100944)
2. Impact of LL-37 on anti-infective immunity. DM Bowdish, DJ Davidson, YE Lau, K Lee, MG Scott, RE Hancock, J Leukoc Biol 2005 77 451 459 15569695 (Pubitemid 40489520)
3. Defensins: antimicrobial peptides of innate immunity. T Ganz, Nat Rev Immunol 2003 3 710 720 10.1038/nri1180 12949495 (Pubitemid 41070812)
4. Endogenous production of antimicrobial peptides in innate immunity and human disease. RL Gallo, V Nizet, Curr Allergy Asthma Rep 2003 3 402 409 10.1007/s11882-003-0074-x 12906776 (Pubitemid 38899107)
5. Cationic host defense (antimicrobial) peptides. KL Brown, RE Hancock, Curr Opin Immunol 2006 18 24 30 10.1016/j.coi.2005.11.004 16337365 (Pubitemid 43049644)
6. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. HW Boucher, GH Talbot, JS Bradley, JE Edwards, D Gilbert, LB Rice, et al. Clin Infect Dis 2009 48 1 12 10.1086/595011 19035777
7. Antibiotics for emerging pathogens. MA Fischbach, CT Walsh, Science 2009 325 1089 1093 10.1126/science.1176667 19713519
8. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. RE Hancock, HG Sahl, Nat Biotechnol 2006 24 1551 1557 10.1038/nbt1267 17160061 (Pubitemid 44967479)
9. Rational design of -helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. Y Chen, CT Mant, SW Farmer, RE Hancock, ML Vasil, RS Hodges, J Biol Chem 2005 280 12316 12329 15677462
10. Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides. NP Chongsiriwatana, JA Patch, AM Czyzewski, MT Dohm, A Ivankin, D Gidalevitz, et al. Proc Natl Acad Sci USA 2008 105 2794 2799 10.1073/pnas.0708254105 18287037 (Pubitemid 351723623)
11. Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure-function study. Z Oren, Y Shai, Biochemistry 1997 36 1826 1835 10.1021/bi962507l 9048567 (Pubitemid 27086279)
12. Mimicry of bioactive peptides via non-natural, sequence-specific peptidomimetic oligomers. JA Patch, AE Barron, Curr Opin Chem Biol 2002 6 872 877 10.1016/S1367-5931(02)00385-X 12470744 (Pubitemid 35449350)
13. Mimicry of host-defense peptides by unnatural oligomers: antimicrobial -peptides. EA Porter, B Weisblum, SH Gellman, J Am Chem Soc 2002 124 7324 7330 10.1021/ja0260871 12071741 (Pubitemid 34670441)
14. Structure-activity relationships of antibacterial acyl-lysine oligomers. IS Radzishevsky, T Kovachi, Y Porat, L Ziserman, F Zaknoon, D Danino, et al. Chem Biol 2008 15 354 362 10.1016/j.chembiol.2008.03.006 18420142 (Pubitemid 351508428)
15. Improving on nature's defenses: optimization & high throughput screening of antimicrobial peptides. D Raventos, O Taboureau, PH Mygind, JD Nielsen, CP Sonksen, HH Kristensen, Comb Chem High Throughput Screen 2005 8 219 233 10.2174/1386207053764549 15892624 (Pubitemid 40488602)
16. The role of amphipathicity in the folding, self-association and biological activity of multiple subunit small proteins. E Perez-Paya, RA Houghten, SE Blondelle, J Biol Chem 1995 270 1048 1056 10.1074/jbc.270.3.1048 7836358
17. The relationship between peptide structure and antibacterial activity. JP Powers, RE Hancock, Peptides 2003 24 1681 1691 10.1016/j.peptides.2003.08.023 15019199 (Pubitemid 38198075)
18. Unexpected relationships between structure and function in,-peptides: antimicrobial foldamers with heterogeneous backbones. MA Schmitt, B Weisblum, SH Gellman, J Am Chem Soc 2004 126 6848 6849 10.1021/ja048546z 15174837 (Pubitemid 38855366)
19. Interplay among folding, sequence, and lipophilicity in the antibacterial and hemolytic activities of /-peptides. MA Schmitt, B Weisblum, SH Gellman, J Am Chem Soc 2007 129 417 428 10.1021/ja0666553 17212422 (Pubitemid 46106642)
20. Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity. A Tossi, C Tarantino, D Romeo, Eur J Biochem 1997 250 549 558 10.1111/j.1432-1033.1997.0549a.x 9428709 (Pubitemid 28012699)
21. Dimeric building blocks for solid-phase synthesis of -peptide - peptoid chimeras. G Bonke, L Vedel, M Witt, JW Jaroszewski, CA Olsen, H Franzyk, Synthesis 2008 15 2381 2390
22. peptide/-peptoid chimeras. CA Olsen, G Bonke, L Vedel, A Adsersen, M Witt, H Franzyk, et al. Org Lett 2007 9 1549 1552 10.1021/ol070316c 17352488
23. Antimicrobial, hemolytic, and cytotoxic activities of -peptoid-peptide hybrid oligomers: improved properties compared to natural AMPs. CA Olsen, HL Ziegler, HM Nielsen, N Frimodt-Moller, JW Jaroszewski, H Franzyk, Chembiochem 2010 11 1356 1360 10.1002/cbic.201000232 20503219
24. Cellular uptake and membrane-destabilising properties of -peptide/-peptoid chimeras: lessons for the design of new cell-penetrating peptides. C Foged, H Franzyk, S Bahrami, S Frokjaer, JW Jaroszewski, HM Nielsen, et al. Biochim Biophys Acta 2008 1778 2487 2495 10.1016/j.bbamem.2008.06.020 18675778
25. De novo antimicrobial peptides with low mammalian cell toxicity. MM Javadpour, MM Juban, WC Lo, SM Bishop, JB Alberty, SM Cowell, et al. J Med Chem 1996 39 3107 3113 10.1021/jm9509410 8759631 (Pubitemid 26260315)
26. Interaction with phospholipid bilayers, ion channel formation, and antimicrobial activity of basic amphipathic -helical model peptides of various chain lengths. Y Agawa, S Lee, S Ono, H Aoyagi, M Ohno, T Taniguchi, et al. J Biol Chem 1991 266 20218 20222 1718959 (Pubitemid 21908448)
27. Interaction of cationic antimicrobial peptides with model membranes. L Zhang, A Rozek, RE Hancock, J Biol Chem 2001 276 35714 35722 10.1074/jbc.M104925200 11473117
28. Interaction of an artificial antimicrobial peptide with lipid membranes. L Yu, L Guo, JL Ding, B Ho, SS Feng, J Popplewell, et al. Biochim Biophys Acta 2009 1788 333 344 10.1016/j.bbamem.2008.10.005 19013127
29. Antiplasmodial and prehemolytic activities of -peptide - peptoid chimeras. L Vedel, G Bonke, C Foged, H Ziegler, H Franzyk, JW Jaroszewski, et al. Chembiochem 2007 8 1781 1784 10.1002/cbic.200700385 17854020 (Pubitemid 47612865)
30. The Clinical and Laboratory Standards Institute (CLSI), Guideline M7-A7: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 2006 Approved Standard Seventh Edition
31. Protamine-induced permeabilization of cell envelopes of gram-positive and gram-negative bacteria. C Johansen, A Verheul, L Gram, T Gill, T Abee, Appl Environ Microbiol 1997 63 1155 1159 9055431 (Pubitemid 27098511)
32. Determination of bacterial cell volume with the Coulter Counter. HE Kubitschek, JA Friske, J Bacteriol 1986 168 1466 1467 3536882 (Pubitemid 17226844)
33. Chemical and electrophoretic changes induced by polymyxin B on outer membrane components from Serratia marcescens. DA Brown, JC Tsang, J Antibiot (Tokyo) 1978 31 603 609 (Pubitemid 8402856)
34. Identification of Proteus mirabilis mutants with increased sensitivity to antimicrobial peptides. AJ McCoy, H Liu, TJ Falla, JS Gunn, Antimicrob Agents Chemother 2001 45 2030 2037 10.1128/AAC.45.7.2030-2037.2001 11408219 (Pubitemid 32591694)
35. Intraspecies and temperature-dependent variations in susceptibility of Yersinia pestis to the bactericidal action of serum and to polymyxin B. AP Anisimov, SV Dentovskaya, GM Titareva, IV Bakhteeva, RZ Shaikhutdinova, SV Balakhonov, et al. Infect Immun 2005 73 7324 7331 10.1128/IAI.73.11.7324-7331. 2005 16239530 (Pubitemid 41587633)
36. Lipopolysaccharides of polymyxin B-resistant mutants of Escherichia coli are extensively substituted by 2-aminoethyl pyrophosphate and contain aminoarabinose in lipid A. K Nummila, I Kilpelainen, U Zahringer, M Vaara, IM Helander, Mol Microbiol 1995 16 271 278 10.1111/j.1365-2958.1995.tb02299.x 7565089
37. Amphipathic helical antimicrobial peptides. A Giangaspero, L Sandri, A Tossi, Eur J Biochem 2001 268 5589 5600 10.1046/j.1432-1033.2001.02494.x 11683882
38. Analogous oligo-acyl-lysines with distinct antibacterial mechanisms. S Rotem, IS Radzishevsky, D Bourdetsky, S Navon-Venezia, Y Carmeli, A Mor, FASEB J 2008 22 2652 2661 10.1096/fj.07-105015 18385215
39. Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp. HT Chou, TY Kuo, JC Chiang, MJ Pei, WT Yang, HC Yu, et al. Int J Antimicrob Agents 2008 32 130 138 10.1016/j.ijantimicag.2008.04.003 18586467
40. De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity. B Deslouches, SM Phadke, V Lazarevic, M Cascio, K Islam, RC Montelaro, et al. Antimicrob Agents Chemother 2005 49 316 322 10.1128/AAC.49.1.316-322.2005 15616311 (Pubitemid 40065808)
41. Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane. M Wu, RE Hancock, J Biol Chem 1999 274 29 35 10.1074/jbc.274.1.29 9867806 (Pubitemid 29035025)
42. Lentivirus lytic peptide 1 perturbs both outer and inner membranes of Serratia marcescens. SM Phadke, V Lazarevic, CC Bahr, K Islam, DB Stolz, S Watkins, et al. Antimicrob Agents Chemother 2002 46 2041 2045 10.1128/AAC.46.6.2041-2045.2002 12019137 (Pubitemid 34535243)
43. Synthetic antimicrobial peptide L8 (MHLHKTSRVTLYLL) has membrane permeabilisation and bacterial aggregation activity. E Loit, MT Hincke, I Altosaar, Int J Antimicrob Agents 2010 35 410 411 10.1016/j.ijantimicag.2009.12. 003 20129762
44. Antibiotics acting on the translational machinery. JM Harms, H Bartels, F Schlunzen, A Yonath, J Cell Sci 2003 116 1391 1393 10.1242/jcs.00365 12640024 (Pubitemid 36527486)
45. Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance. FJ Schmitz, PG Higgins, S Mayer, AC Fluit, A Dalhoff, Eur J Clin Microbiol Infect Dis 2002 21 647 659 10.1007/s10096-002- 0788-z 12373497
46. Structure, biochemistry and mechanism of action of glycopeptide antibiotics. PE Reynolds, Eur J Clin Microbiol Infect Dis 1989 8 943 950 10.1007/BF01967563 2532132 (Pubitemid 20006106)
47. Evidences for complex formation between polymyxin B and lipopolysaccharides from Serratia marcescens. JC Tsang, DA Weber, DA Brown, J Antibiot (Tokyo) 1976 29 735 742
48. The bacterial outer membrane as a drug barrier. RE Hancock, Trends Microbiol 1997 5 37 42 10.1016/S0966-842X(97)81773-8 9025234 (Pubitemid 27077171)
49. Bacterial membrane lipids in the action of antimicrobial agents. RM Epand, RF Epand, J Pept Sci 2010
50. Peptide antibiotics. RE Hancock, DS Chapple, Antimicrob Agents Chemother 1999 43 1317 1323 10348745 (Pubitemid 29259318)
51. The structure, dynamics and orientation of antimicrobial peptides in membranes by multidimensional solid-state NMR spectroscopy. B Bechinger, Biochim Biophys Acta 1999 1462 157 183 10.1016/S0005-2736(99)00205-9 10590307
52. The cytoplasmic membrane is a primary target for the staphylocidal action of thrombin-induced platelet microbicidal protein. SP Koo, MR Yeaman, CC Nast, AS Bayer, Infect Immun 1997 65 4795 4800 9353067 (Pubitemid 27463259)
53. Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II. T Schneider, T Kruse, R Wimmer, I Wiedemann, V Sass, U Pag, et al. Science 2010 328 1168 1172 10.1126/science.1185723 20508130
54. Apidaecin-type peptide antibiotics function through a non-poreforming mechanism involving stereospecificity. P Casteels, P Tempst, Biochem Biophys Res Commun 1994 199 339 345 10.1006/bbrc.1994.1234 8123032
55. Antibacterial properties and mode of action of a short acyl-lysyl oligomer. F Zaknoon, H Sarig, S Rotem, L Livne, A Ivankin, D Gidalevitz, et al. Antimicrob Agents Chemother 2009 53 3422 3429 10.1128/AAC.00010-09 19487442
56. Phosphate efflux through the channels formed by colicins and phage T5 in Escherichia coli cells is responsible for the fall in cytoplasmic ATP. G Guihard, H Benedetti, M Besnard, L Letellier, J Biol Chem 1993 268 17775 17780 7688731 (Pubitemid 23260286)
57. A plausible mode of action of pseudin-2, an antimicrobial peptide from Pseudis paradoxa. SC Park, JY Kim, C Jeong, S Yoo, KS Hahm, Y Park, Biochim Biophys Acta 2011 1808 171 182 10.1016/j.bbamem.2010.08.023 20826126
58. Sequence-dependent interaction of -peptides with membranes. J Mondal, X Zhu, Q Cui, A Yethiraj, J Phys Chem B 2010 114 13585 13592 10.1021/jp1070242 20882985
59. Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus. R Novick, Virology 1967 33 155 166 10.1016/0042-6822(67) 90105-5 4227577
60. Pedigrees of some mutant strains of Escherichia coli K-12. BJ Bachmann, Bacteriol Rev 1972 36 525 557 4568763
61. In vitro and in vivo invasiveness of different pulsed-field gel electrophoresis types of Listeria monocytogenes. CN Larsen, B Norrung, HM Sommer, M Jakobsen, Appl Environ Microbiol 2002 68 5698 5703 10.1128/AEM.68.11.5698-5703.2002 12406767 (Pubitemid 35265710)
62. One group of genetically similar Listeria monocytogenes strains frequently dominates and persists in several fish slaughter- and smokehouses. G Wulff, L Gram, P Ahrens, BF Vogel, Appl Environ Microbiol 2006 72 4313 4322 10.1128/AEM.02288-05 16751546 (Pubitemid 43898662)